Jim Simons Hutchmed (China) LTD Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 129,000 shares of HCM stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
129,000
Previous 135,200
4.59%
Holding current value
$1.91 Million
Previous $2.03 Million
4.53%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding HCM
# of Institutions
62Shares Held
6.07MCall Options Held
0Put Options Held
0-
Schroder Investment Management Group London, X02.58MShares$38.3 Million0.03% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M925KShares$13.7 Million0.02% of portfolio
-
State Street Corp Boston, MA329KShares$4.88 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.68 Million0.11% of portfolio
-
Goldman Sachs Group Inc New York, NY289KShares$4.29 Million0.0% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.57B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...